Abstract
Hypertrophic cardiomyopathy (HCM) is a common inherited cardiovascular disease and is characterized by hypertrophy of the left ventricle. We reprogrammed peripheral blood mononuclear cells (PBMCs) from a HCM patient into pluripotent stem cells (iPSC) (YCMi006-A) carrying a heterozygous c.1029C > G mutation in ACTA1. The YCMi006-A cells expressed high levels of pluripotent markers, had a normal 46XX karyotype and demonstrated the capacity to differentiate into derivatives of all three germ layers. This cell line can be a valuable tool for investigating the pathogenesis of HCM.
Original language | English (US) |
---|---|
Article number | 102874 |
Journal | Stem Cell Research |
Volume | 63 |
DOIs | |
State | Published - Aug 2022 |
Externally published | Yes |
ASJC Scopus subject areas
- Cell Biology
- Developmental Biology